Autopsy report · NCT05361109

Baricitinib for Cutaneous Dermatomyositis

“Difficulty recruiting subjects”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

University of Washington

Sponsor type

University, hospital or other

Conditions

Dermatomyositis

Interventions

Baricitinib

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated Breasts
  “Difficulty in recruiting research subjects” (88% match in meaning)
• Home Program Education for Patients With Low Back Pain
  “Not recruiting subjects currently” (85% match in meaning)
• In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
  “Not able to recruit subjects” (85% match in meaning)
• Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
  “Unable to recruit any subjects” (83% match in meaning)
• Vitamin D Versus Placebo in the Treatment of Vague Musculoskeletal Pain in Children
  “inability to recruit subjects” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.